Literature DB >> 17427969

Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery.

Jan Willem B de Groot1, Thera P Links, Willem J Sluiter, Bruce H R Wolffenbuttel, Theo Wiggers, John Th M Plukker.   

Abstract

BACKGROUND: Extent of neck dissection is controversial in patients with palpable medullary thyroid cancer (MTC).
METHODS: We evaluated 64 MTC patients (19 hereditary, 45 sporadic) with palpable thyroid nodules (group 1, n = 35) or palpable lymph node metastases (group 2, n = 29). Standard surgery included total thyroidectomy, central compartment dissection, and additional neck dissection on indication.
RESULTS: In group 1, 40% of the patients were cured. Thirty-one percent of all patients had central, 23% ipsilateral, 14% contralateral, and 14% mediastinal, metastases. Fifty-one percent developed locoregional recurrence. Locoregional recurrence (p = .043) and reoperations (p = .020) were noted more often after a less than standard initial procedure. In group 2, no patients were cured. All had central, 93% ipsilateral, 45% contralateral, and 52% mediastinal metastases. Thirty-eight percent developed locoregional recurrence.
CONCLUSIONS: Locoregional recurrence frequently occurs in palpable MTC, and tumor control may be improved by standard central, bilateral, and upper mediastinal neck dissection. (c) 2007 Wiley Periodicals, Inc. Head Neck, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17427969     DOI: 10.1002/hed.20609

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.

Authors:  Dana T Yip; Maria Hassan; Kalliopi Pazaitou-Panayiotou; Daniel T Ruan; Atul A Gawande; Randall D Gaz; Francis D Moore; Richard A Hodin; Antonia E Stephen; Peter M Sadow; Gilbert H Daniels; Gregory W Randolph; Sareh Parangi; Carrie C Lubitz
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

2.  The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

Authors:  Mohsen Beheshti; Sigrid Pöcher; Reza Vali; Peter Waldenberger; Gabriele Broinger; Michael Nader; Susanne Kohlfürst; Christian Pirich; Henning Dralle; Werner Langsteger
Journal:  Eur Radiol       Date:  2009-01-21       Impact factor: 5.315

3.  A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the mayo clinic experience.

Authors:  Jason A Call; Jonathan S Caudill; Bryan McIver; Robert L Foote
Journal:  Rare Tumors       Date:  2013-07-12

4.  Prognostic significance and optimal cutoff of age in medullary thyroid cancer.

Authors:  Ning Qu; Rong-Liang Shi; Ting-Xian Luo; Yu-Long Wang; Duan-Shu Li; Yu Wang; Cai-Ping Huang; Qing-Hai Ji
Journal:  Oncotarget       Date:  2016-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.